Tavager 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

tavager 500 mg film-coated tablets

mcdermott laboratories ltd., t/a gerard laboratories - levofloxacin - film-coated tablet - 500 milligram(s) - fluoroquinolones; levofloxacin

Levofloxacin 5mg/ml Solution for Infusion (50ml vial) Malta - English - Medicines Authority

levofloxacin 5mg/ml solution for infusion (50ml vial)

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - solution for infusion - levofloxacin 5 mg/ml - antibacterials for systemic use

Levoxa 250mg film-coated Tablets Malta - English - Medicines Authority

levoxa 250mg film-coated tablets

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - film-coated tablet - levofloxacin 250 mg - antibacterials for systemic use

Levoxa 500mg film-coated Tablets Malta - English - Medicines Authority

levoxa 500mg film-coated tablets

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - film-coated tablet - levofloxacin 500 mg - antibacterials for systemic use

Levofloxacin Krka 250 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

levofloxacin krka 250 mg film-coated tablets

krka, d.d., novo mesto - levofloxacin hemihydrate - film-coated tablet - 250 milligram(s) - fluoroquinolones; levofloxacin - pharmacotherapeutic group: quinolone antibacterials, fluoroquinolones, - it is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): - acute bacterial sinusitis. - acute exacerbations of chronic bronchitis. - community-acquired pneumonia. - complicated skin and soft tissue infections

Levofloxacin Krka 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

levofloxacin krka 500 mg film-coated tablets

krka, d.d., novo mesto - levofloxacin hemihydrate - film-coated tablet - 500 milligram(s) - fluoroquinolones; levofloxacin - quinolone antibacterials, fluoroquinolones - it is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): - acute bacterial sinusitis. - acute exacerbations of chronic bronchitis. - community-acquired pneumonia. - complicated skin and soft tissue infections

Levofloxacin 5mg/ml Solution for Infusion (100ml vial) Malta - English - Medicines Authority

levofloxacin 5mg/ml solution for infusion (100ml vial)

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - solution for infusion - levofloxacin 5 mg/ml - antibacterials for systemic use

Levofloxacin 5mg/ml Solution for infusion, glass bottle Ireland - English - HPRA (Health Products Regulatory Authority)

levofloxacin 5mg/ml solution for infusion, glass bottle

baxter holding b.v. - levofloxacin hemihydrate - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin

Levofloxacin 5mg/ml Solution for infusion, Non PVC bag Ireland - English - HPRA (Health Products Regulatory Authority)

levofloxacin 5mg/ml solution for infusion, non pvc bag

baxter holding b.v. - levofloxacin hemihydrate - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin

Levofloxacin NORMON 5 mg/ml Infusionslösung Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

levofloxacin normon 5 mg/ml infusionslösung